Invesco’s Aimmune Therapeutics AIMT Stock Holding History

Invesco’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,344	Closed	-$356K	–	3882
2020 Q3	$356K	Sell	10,344 -102	-1%	-$2.17K	﹤0.01%	3255
2020 Q2	$174K	Sell	10,446 -853	-8%	-$14.5K	﹤0.01%	3510
2020 Q1	$163K	Buy	+11,299	New	+$289K	﹤0.01%	3463
2018 Q2	–	Sell	-68,753	Closed	-$2.19M	–	3936
2018 Q1	$2.19M	Buy	+68,753	New	+$2.42M	﹤0.01%	2524
2017 Q3	–	Sell	-56,197	Closed	-$1.16M	–	3688
2017 Q2	$1.16M	Buy	+56,197	New	+$1.07M	﹤0.01%	2938

Invesco's AIMT Position: Q4 2020 in Review

Invesco sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 10,344 shares — an estimated $356K sold.

Invesco first reported a position in AIMT in Q2 2017 and held it in 5 quarters. The position peaked at $2.19M in Q1 2018. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Invesco reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Invesco sold 10,344 Aimmune Therapeutics shares in Q4 2020, an estimated $356K.
Invesco first reported a position in Aimmune Therapeutics in Q2 2017 and held it in 5 quarters.
Invesco's Aimmune Therapeutics position peaked at $2.19M in Q1 2018.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.